Viridien Shares Climb 2.54% Following Two Target Upgrades

Analysts Upgrade Valuation Estimates

Recently, two research firms significantly revised their valuation estimates upwards. Oddo BHF raised its target from 100 to 130 euros this Thursday, while maintaining a neutral stance on the stock. A few days earlier, on January 19, Barclays had already increased its target from 100 to 150 euros, also maintaining a market-weight recommendation. These price adjustments reflect a reevaluation of the group's growth potential, although both institutions remain cautious in their recommendations. The average target of analysts is now well above current levels. With a price at 125.20 euros, the valuation remains below the set targets, suggesting a theoretical appreciation margin according to these estimates. This convergence in revisions is an important signal for investors seeking clarity on the stock's trajectory in the coming months.

Technical Analysis of Viridien's Stock

From a technical perspective, Viridien is trading above its main moving averages, indicating a favorable underlying trend. The stock is trading well above its 50-day average at 105.84 euros and even more so above its 200-day average at 75.37 euros. The technical resistance identified at 128.60 euros is the next major hurdle, only a few points away from the current level. The RSI at 47 indicates a balanced situation, without any pronounced overbought or oversold conditions. The company's agenda includes the publication of its 2025 annual results on February 26, which could influence the course's trajectory. Investors will particularly monitor these figures after a year marked by strong stock appreciation. The one-month volatility stands at 10.52, while the limited beta of 0.11 shows a low correlation with general market movements, a characteristic of specialized sector values.